ArticleBlood advances2025

Outcomes in frail patients receiving BCMA-directed bispecific antibodies for relapsed/refractory multiple myeloma.

Benjamin Adegbite et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.